Davis Blaine's Form 4 filing
Cartesian Therapeutics, Inc. (RNAC) · filed Jan 7, 2025
- Accession no.
- 0001453687-25-000035
- Filed
- Jan 7, 2025
- Trade date
- Jan 3-6, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $134.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis BlaineCIK 0001802188 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
Referenced by the price of 2 transactions in Table I.